We found that tumor-infiltrating PD-1+ CD3+ CD+ T cells expressed higher CD69 and HLA-DR than tumor-infiltrating PD-1− CD3+ CD+ T cells isolated from the same samples, which suggest PD-1+ subset in tumor-infiltrating CD3+ CD+ T cells are more activated. The gene discussed is CD69; the disease is neoplasm.